AUROBINDO PHARMA
Back to Cashflow Statement
|
AUROBINDO PHARMA Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹120 Cr | ₹800 Cr | ₹1,814 Cr | ₹-2,969 Cr | ₹-1,365 Cr |
What is the latest Cash Flow from Financing Activities ratio of AUROBINDO PHARMA ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹120 Cr |
| Mar2024 | ₹800 Cr |
| Mar2023 | ₹1,814 Cr |
| Mar2022 | ₹-2,969 Cr |
| Mar2021 | ₹-1,365 Cr |
How is Cash Flow from Financing Activities of AUROBINDO PHARMA Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹120 Cr | -85.04 | |
| Mar2024 | ₹800 Cr | -55.89 | |
| Mar2023 | ₹1,814 Cr | Positive | |
| Mar2022 | ₹-2,969 Cr | Negative | |
| Mar2021 | ₹-1,365 Cr | - | |
Compare Cash Flow from Financing Activities of peers of AUROBINDO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AUROBINDO PHARMA | ₹69,182.0 Cr | 1.4% | -3.6% | 3.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,615.0 Cr | 4% | -4.9% | -2.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,943.0 Cr | 1.1% | -9.3% | 9.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹133,336.0 Cr | -1.3% | -3.7% | 24% | Stock Analytics | |
| CIPLA | ₹107,499.0 Cr | 1.5% | -9.3% | -7.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,590.0 Cr | 5% | -0.1% | 3.3% | Stock Analytics | |
AUROBINDO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AUROBINDO PHARMA | 1.4% |
-3.6% |
3.5% |
| SENSEX | 3.5% |
-1.7% |
7.8% |
You may also like the below Video Courses